Current and historical daily PE Ratio for Merrimack Pharmaceuticals Inc (
) from 2012 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Merrimack Pharmaceuticals stock (MACK) PE ratio as of Jun 09 2024 is 1.09.
More Details
Merrimack Pharmaceuticals Inc (MACK) PE Ratio (TTM) Chart
Merrimack Pharmaceuticals Inc (MACK) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1236
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Merrimack Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 1.1 | 2024-03-21 | At Loss |
| 2024-05-23 | 1.1 | 2024-03-20 | At Loss |
| 2024-05-22 | 1.1 | 2024-03-19 | At Loss |
| 2024-05-21 | 1.1 | 2024-03-18 | At Loss |
| 2024-05-20 | 1.1 | 2024-03-15 | At Loss |
| 2024-05-17 | 1.1 | 2024-03-14 | At Loss |
| 2024-05-16 | 1.1 | 2024-03-13 | At Loss |
| 2024-05-15 | 1.1 | 2024-03-12 | At Loss |
| 2024-05-14 | 1.1 | 2024-03-11 | At Loss |
| 2024-05-13 | 1.1 | 2024-03-08 | At Loss |
| 2024-05-10 | 1.1 | 2024-03-07 | At Loss |
| 2024-05-09 | 1.1 | 2024-03-06 | At Loss |
| 2024-05-08 | 1.1 | 2024-03-05 | At Loss |
| 2024-05-07 | 1.1 | 2024-03-04 | At Loss |
| 2024-05-06 | 1.1 | 2024-03-01 | At Loss |
| 2024-05-03 | 1.1 | 2024-02-29 | At Loss |
| 2024-05-02 | 1.1 | 2024-02-28 | At Loss |
| 2024-05-01 | 1.1 | 2024-02-27 | At Loss |
| 2024-04-30 | 1.1 | 2024-02-26 | At Loss |
| 2024-04-29 | 1.1 | 2024-02-23 | At Loss |
| 2024-04-26 | 1.1 | 2024-02-22 | At Loss |
| 2024-04-25 | 1.1 | 2024-02-21 | At Loss |
| 2024-04-24 | 1.1 | 2024-02-20 | At Loss |
| 2024-04-23 | 1.1 | 2024-02-16 | At Loss |
| 2024-04-22 | 1.1 | 2024-02-15 | At Loss |
| 2024-04-19 | 1.1 | 2024-02-14 | At Loss |
| 2024-04-18 | 1.1 | 2024-02-13 | At Loss |
| 2024-04-17 | 1.1 | 2024-02-12 | At Loss |
| 2024-04-16 | 1.1 | 2024-02-09 | At Loss |
| 2024-04-15 | 1.1 | 2024-02-08 | At Loss |
| 2024-04-12 | 1.1 | 2024-02-07 | At Loss |
| 2024-04-11 | 1.1 | 2024-02-06 | At Loss |
| 2024-04-10 | 1.1 | 2024-02-05 | At Loss |
| 2024-04-09 | 1.1 | 2024-02-02 | At Loss |
| 2024-04-08 | 1.1 | 2024-02-01 | At Loss |
| 2024-04-05 | 1.1 | 2024-01-31 | At Loss |
| 2024-04-04 | 1.1 | 2024-01-30 | At Loss |
| 2024-04-03 | 1.1 | 2024-01-29 | At Loss |
| 2024-04-02 | 1.1 | 2024-01-26 | At Loss |
| 2024-04-01 | 1.1 | 2024-01-25 | At Loss |
| 2024-03-28 | 1.1 | 2024-01-24 | At Loss |
| 2024-03-27 | At Loss | 2024-01-23 | At Loss |
| 2024-03-26 | At Loss | 2024-01-22 | At Loss |
| 2024-03-25 | At Loss | 2024-01-19 | At Loss |
| 2024-03-22 | At Loss | 2024-01-18 | At Loss |
Merrimack Pharmaceuticals Inc (MACK) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Merrimack Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US5903282094
Description
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers